← Browse by Condition
Medical Condition

vaping

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for vaping sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — vaping Clinical Trials

How many clinical trials are currently recruiting for vaping?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for vaping, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for vaping?
vaping research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a vaping clinical trial?
Eligibility criteria for vaping trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
University of Miami 1 trial
University of Zurich 1 trial
Yale University 1 trial
Laval University 1 trial
Centre for Addiction and Mental Health 1 trial

Recruiting Clinical Trials

NCT05454267
Recruiting

Early Detection of Vaping-related Vascular Diseases

Enrollment
90 pts
Location
United States
Sponsor
University of Miami
View Trial →
NCT07568483
Recruiting

TUBSIS 2.0 - Tobacco Use Behavioral Support and Intervention System

Enrollment
406 pts
Location
Switzerland
Sponsor
University of Zurich
View Trial →
NCT07040566 Phase 2
Recruiting

A Trial of Varenicline for E-cigarette Cessation

Enrollment
326 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT06291597
Recruiting

Vaping Adverse Lung and Heart Events Cohort

Enrollment
250 pts
Location
Canada
Sponsor
Laval University
View Trial →
NCT06885606
Recruiting

The Use of tDCS for Vaping Reduction

Enrollment
40 pts
Location
Canada
Sponsor
Centre for Addiction and Menta...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology